Related Experiment Video
Updated: Jun 20, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Evaluation of new indole and bromoindole derivatives as pp60(c-Src) tyrosine kinase inhibitors
Zühal Kiliç1, Yasemin G Işgör, Süreyya Olgen
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ankara, 06100, Tandoğan-Ankara, Turkey.
Abstract:
A series of N-benzyl-indole-3-imine-, amine derivatives and their 5-bromo congeners were synthesized and their biological activity were evaluated against the pp60(c-Src) tyrosine kinase target. To afford the imine derivatives, aldehydes were reacted with substituted benzylamines and the corresponding amine derivatives were obtained by NaBH(4) reduction of these imines. Except insoluble N-benzyl-indole-3-imine derivatives, all the derivatives showed some activity against the kinase target. Screening of these compounds for their biological activity revealed that among N-benzyl-indole derivatives, those bearing 5-bromo substitution have the enhanced potency, where the amine derivatives were more active than imines.
Related Concept Videos
Receptor Tyrosine Kinases
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
